Pertuzumab after surgery for early breast cancer not cost effective, says NICE
Women with a type of early breast cancer may not benefit from continuing or starting a drug after having surgery, NICE says in draft guidance.
Source: NHS Networks - Category: UK Health Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | National Institute for Health and Clinical Excelle | UK Health | Women